North America Respiratory Care Devices Market Outlook, 2031
The Global Respiratory Care Devices Market is segmented into By Product Type (Therapeutic Devices [Inhalers, Ventilators, Positive Airway Pressure (PAP) Devices, Humidifiers, Nebulizers, Others (Oxygen Concentrators, Oxygen Hood)], Monitoring Devices [Pulse Oximeters, Gas Analyzers, Others], Diagnostic Devices [Spirometers, Polysomnography Devices, Peak Flow Meters, Others], Consumables and Accessories [Disposable Resuscitators, Breathing Circuits, Masks, Tracheostomy Tubes, Others (Nasal Cannulas)]); By Disease Indication (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, Other Disease Indications [Respiratory Distress Syndrome, Cystic Fibrosis]); By End User (Hospitals, Ambulatory Care Centers (ACCs), Home Care Settings, Other End User).
- Bonafide Research
- 10-01-2026
- Pages : 80
- Figures : 6
- Tables : 14
- Region : North America
- Category : Lifescience & Healthcare
- Healthcare
- Schedule a Call
-
Sikandar Kesari — Research Analyst
The North America Respiratory Devices market was valued at more than USD 11.92 Billion in 2025.
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Market Size (2025) USD 11.92 Billion
- Largest Market United States
- Fastest Market Mexico
- Format
Featured Companies
- 1. Marico Limited
- 2. Medline Industries, LP
- 3. Invacare
- 4. Koninklijke Philips N.V.
- 5. Nidek Medical Products Inc.
- 6. Precision Medical, Inc.
- More...
Market Analysis
The market for respiratory devices in North America has seen considerable growth, propelled by sophisticated healthcare systems, elevated awareness of diseases, and strong adoption in clinical settings. The main aim of respiratory devices in North America focuses on the prevention, diagnosis, treatment, and ongoing management of respiratory issues within hospitals, clinics, and at-home care. Historically, this area was one of the first to utilize mechanical ventilators, metered-dose inhalers, nebulizers, CPAP and BiPAP devices, and oxygen therapy systems, mainly due to the widespread occurrence of chronic respiratory illnesses like asthma, chronic obstructive pulmonary disease COPD, and sleep apnea. Functionally, respiratory devices are medical tools intended to aid or enhance lung function by delivering oxygen, medicine, or assisted breathing, thus improving airflow, gas transfer, and the efficiency of patient breathing. In practical scenarios, these devices significantly alleviate symptoms, enhance life quality, and decrease hospital admission rates, especially for older adults. Ongoing research and innovation from manufacturers have boosted market acceptance by introducing advancements such as smart inhalers that track doses, AI-integrated ventilators for critical care improvement, and remote monitoring systems linked to digital health solutions. Adherence to regulations and certifications, including FDA approvals, ISO quality guidelines, and clinical validation processes, is essential for ensuring product safety, precision, and therapeutic efficacy, while also fostering trust among healthcare professionals and patients. According to the research report, " North America Respiratory Devices Market Outlook, 2031," published by Bonafide Research, the North America Respiratory Devices market was valued at more than USD 11.92 Billion in 2025. Recent changes in the market feature the swift growth of connected respiratory equipment, greater acceptance of home healthcare options, and the incorporation of digital health technologies to assist in managing chronic illnesses. The movement toward outpatient care and home-based healthcare has stimulated the design of portable, user-friendly, and interconnected respiratory devices that enhance patient adherence and lower healthcare expenses. Leading companies in the market, such as Medtronic, ResMed, GE Healthcare, and Philips, dominate the competitive field by providing a wide range of products from advanced ventilators and sleep apnea machines to oxygen concentrators and digital respiratory solutions. These firms concentrate on innovation, forming strategic alliances, and differentiating their products to meet the changing clinical demands. Important opportunities in the market arise from the growing elderly population, favorable reimbursement policies, the rising incidence of respiratory diseases, and an increasing need for long-term home respiratory support. These factors offer ongoing growth potential by increasing patient access, improving treatment results, and promoting the long-term development of respiratory care options throughout North America.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
• Widespread occurrence of chronic respiratory illnesses: In North America, there is a significant and escalating prevalence of chronic respiratory illnesses, including COPD, asthma, and sleep apnea. It is mainly influenced by an aging population, lifestyle choices, and the long-standing history of smoking. The practice of early detection and diagnosis is common, which results in a larger number of patients receiving treatment. These ailments typically necessitate ongoing therapy, leading to a sustained demand for respiratory equipment. Medical facilities, outpatient clinics, and homecare environments depend heavily on equipment like ventilators, inhalers, and CPAP machines. Increased awareness among patients fosters a proactive approach to managing these conditions.
• Robust healthcare system and insurance coverage: The region enjoys a strong healthcare system with extensive access to innovative medical technologies. Supportive reimbursement policies from both public and private insurance providers facilitate the use of respiratory devices. There is a rising trend in insurers covering home respiratory therapy, which leads patients to prefer treatments that can be done in their own residences. Medical institutions are financially prepared to invest in cutting-edge ventilatory and monitoring technologies. Substantial healthcare expenditures boost the rapid adoption of advanced technologies. This scenario lowers financial hurdles for healthcare providers and patients alike. Market Challenges
• Expensive advanced respiratory equipment: The cost of sophisticated respiratory devices that feature digital and AI technologies is high, which affects their affordability. Small medical establishments and uninsured individuals often face financial limitations. Significant upfront expenses can delay the decision to purchase, even when clinical advantages are apparent. Upkeep and software updates further add to the total cost of ownership. Such cost concerns are especially prevalent in long-term home therapy situations. Sensitivity to pricing might hinder the adoption of high-end products, presenting a challenge for market growth among budget-conscious consumers.
• Strict regulatory standards: The approval process set by the FDA for respiratory devices is thorough and lengthy. Manufacturers are required to adhere to stringent safety, efficacy, and quality regulations. Complying with these regulations can prolong development timelines and escalate costs. Issues like product recalls or failing to conform to regulations can have considerable negative effects on a brand's reputation. Smaller enterprises frequently find it challenging to manage the costs related to compliance. Ongoing monitoring after the product hits the market is mandatory. These elements can hinder innovation and the entry of new products into the market. Market Trends
• Rise of home-based respiratory treatment: There is a notable movement towards providing respiratory treatment in home settings across North America. Patients often prefer receiving care at home because it is more comfortable and cost-effective. Technological progress has led to the creation of portable and user-friendly devices. Receiving care at home can help reduce hospital readmissions and lessen the strain on healthcare systems. Insurers are also becoming more supportive of offering reimbursement for home therapy services. This trend is transforming how devices are designed and distributed. Manufacturers are concentrating on creating compact and connected technologies.
• Integration of digital and connected devices: There is a growing integration of respiratory devices with digital health systems. Smart inhalers and connected ventilators facilitate real-time tracking and information sharing. AI technology is utilized to enhance therapy settings and improve patient outcomes. Remote monitoring enables proactive clinical responses. Analyzing data increases treatment adherence and effective disease management. This development coincides with the growth of telehealth services. The shift toward digital solutions is emerging as a significant competitive edge in the market.
Segmentation
| By Product Type | Therapeutic Devices | |
| Monitoring Devices | ||
| Diagnostic Devices | ||
| Consumables and Accessories | ||
| By Disease Indication | Chronic Obstructive Pulmonary disease (COPD) | |
| Sleep Apnea | ||
| Asthma | ||
| Infectious Diseases | ||
| Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis) | ||
| By End User | Hospitals | |
| Ambulatory Care Centers (ACCs) | ||
| Home care Settings | ||
| Other End User | ||
| North America | United States | |
| Canada | ||
| Mexico | ||
Therapeutic tools lead the North America respiratory devices market due to the high rates of chronic respiratory conditions that need long-term care and good reimbursement support. The byproduct types therapeutic devices section is the largest in the North America respiratory devices market mainly because this region faces a significant number of long-term and worsening respiratory diseases requiring ongoing treatment instead of just short-term checks. Conditions like chronic obstructive pulmonary disease COPD, asthma, sleep apnea, and respiratory problems after COVID-19 are common, especially among older individuals. These issues call for the extended use of therapeutic tools like ventilators, CPAP and BiPAP machines, oxygen concentrators, nebulizers, and inhalers. North America’s well-developed healthcare system allows for early detection and long-term management of these illnesses, greatly boosting the need for therapeutic options in hospitals, clinics, and home care settings. Favorable reimbursement policies from both public and private insurers further enhance the acceptance of therapeutic respiratory tools, particularly for at-home treatment, easing financial challenges for patients. Heightened patient awareness and doctor preference for evidence-based treatment options support the ongoing use of these devices. Major manufacturers in the region also continuously develop innovative therapeutic technologies, improving efficiency, user comfort, and adherence. The healthcare focus after the pandemic has also intensified investments in critical care and respiratory therapy readiness. The combination of a high prevalence of diseases, a demand for long-term care, reimbursement support, and advancements in technology establishes therapeutic tools as the leading product type in the North America respiratory devices market. The high prevalence of COPD is due to long-term smoking habits, an aging population, and good access to diagnosis and long-term respiratory care technologies. Chronic Obstructive Pulmonary Disease COPD stands out as the most significant disease indication in the North America respiratory devices market due to a mix of health, lifestyle, and demographic factors. In North America, especially in the United States, the prevalence of COPD is among the highest in the world, mainly linked to decades of smoking, job-related exposures, and pollution. The aging citizenry in the area further elevates the burden of the disease, as the rate of COPD rises sharply with increased age. From a healthcare viewpoint, the region enjoys advanced diagnostic tools, wide use of spirometry tests, and early identification of the disease, which broadens the number of treated patients. Managing COPD tends to be a long-term and device-focused process, requiring regular use of inhalers, nebulizers, oxygen therapy systems, non-invasive ventilation equipment, and portable concentrators, which maintains steady demand. Significant healthcare spending, supportive reimbursement strategies, and a strong shift towards at-home respiratory devices bolster market leadership. Frequent flare-ups of COPD lead to hospital admissions and the need for post-acute respiratory assistance, further elevating device usage in both medical facilities and home environments. Rapid technological advancements, like smart inhalers and remote monitoring systems, are quickly embraced in North America, enhancing patient compliance and outcomes while increasing device availability. The presence of combination therapies that integrate pharmaceuticals and devices, along with many respiratory device makers, also plays a role in expanding the market. The chronic and progressive characteristics of COPD, coupled with the readiness of the healthcare system and high levels of patient awareness, position it as the largest disease indication in the North America respiratory devices market. Hospitals lead the North America respiratory devices market due to a significant number of patients requiring acute and chronic respiratory care, aided by advanced infrastructure and critical care abilities. The by End User Hospitals section is the largest part of the North America respiratory devices market since hospitals are key locations for the diagnosis, immediate treatment, and ongoing management of respiratory illnesses throughout the area. There is a high rate of severe respiratory issues in North America, including COPD flare-ups, acute respiratory distress syndrome ARDS, pneumonia, and breathing problems after surgery, all of which necessitate care within hospitals. These facilities have modern intensive care units ICUs, emergency rooms, and dedicated pulmonary departments that depend significantly on ventilators, oxygen therapy devices, nebulizers, and sophisticated monitoring tools. Strong investment in healthcare allows hospitals to purchase expensive, cutting-edge respiratory devices. Furthermore, hospitals are the main sites for addressing public health crises and infectious respiratory outbreaks, which further supports their leading role in using respiratory devices. Favorable reimbursement policies bolster hospital-based respiratory treatments, maintaining a consistent demand for such devices. The availability of trained healthcare workers also increases the reliance on hospitals for complicated respiratory care. , the combination of high patient numbers, advanced facilities, and specialized clinical knowledge establishes hospitals as the largest end-user group in North America.
to Download this information in a PDF
Market Regional Insights
The United States holds the top position in the North America respiratory devices market because of its advanced healthcare ecosystem, significant disease occurrence, high innovation potential, and considerable healthcare expenditure. The United States is at the forefront of the North America respiratory devices market owing to its sophisticated healthcare system, significant levels of innovation, and a large number of patients needing respiratory treatment. The nation has one of the highest rates of chronic respiratory illnesses, including COPD, asthma, and sleep apnea, influenced by an aging population, lifestyle choices, and a history of smoking. This results in a steady demand for both therapeutic and monitoring devices in hospitals, clinics, and home care settings. Furthermore, the U.S. has a well-established reimbursement system through Medicare, Medicaid, and private insurance, aiding in the uptake of advanced devices, especially for long-term and home care. The presence of leading manufacturers and innovators, like Medtronic, GE Healthcare, ResMed, and Philips with significant operations in the U.S., boosts local production, research, and product commercialization. Important investments in research and development allow for quick integration of AI-powered ventilators, smart inhalers, and connected monitoring solutions. The nation's wide network of hospitals, sophisticated intensive care facilities, and readiness for public health challenges also enhance device use. Strong regulatory supervision by the FDA guarantees high safety and performance standards, building trust among clinicians and patients. All these elements establish the United States as the primary player in the North America respiratory devices market.
to Download this information in a PDF
Companies Mentioned
- Marico Limited
- Medline Industries, LP
- Invacare
- Koninklijke Philips N.V.
- Nidek Medical Products Inc.
- Precision Medical, Inc.
- ResMed
- Teijin Limited
- Besco Medical Limited
- Masimo
- Nihon Kohden Corporation
- Siemens AG
- Cardinal Health, Inc.
- Fisher & Paykel Healthcare Corporation Limited
- Medtronic plc
- Stryker corporation
- Vapotherm Inc.
- Getinge AB
- Dragerwerk AG & Co. KGaA
- Juki Corporation
- Trudell Medical International
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. North America Respiratory Devices Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Country
- 6.3. Market Size and Forecast, By Product Type
- 6.4. Market Size and Forecast, By Disease Indication
- 6.5. Market Size and Forecast, By End User
- 6.6. United States Respiratory Devices Market Outlook
- 6.6.1. Market Size by Value
- 6.6.2. Market Size and Forecast By Product Type
- 6.6.3. Market Size and Forecast By End User
- 6.7. Canada Respiratory Devices Market Outlook
- 6.7.1. Market Size by Value
- 6.7.2. Market Size and Forecast By Product Type
- 6.7.3. Market Size and Forecast By End User
- 6.8. Mexico Respiratory Devices Market Outlook
- 6.8.1. Market Size by Value
- 6.8.2. Market Size and Forecast By Product Type
- 6.8.3. Market Size and Forecast By End User
- 7. Competitive Landscape
- 7.1. Competitive Dashboard
- 7.2. Business Strategies Adopted by Key Players
- 7.3. Porter's Five Forces
- 7.4. Company Profile
- 7.4.1. Koninklijke Philips N.V.
- 7.4.1.1. Company Snapshot
- 7.4.1.2. Company Overview
- 7.4.1.3. Financial Highlights
- 7.4.1.4. Geographic Insights
- 7.4.1.5. Business Segment & Performance
- 7.4.1.6. Product Portfolio
- 7.4.1.7. Key Executives
- 7.4.1.8. Strategic Moves & Developments
- 7.4.2. Medtronic plc
- 7.4.3. Masimo Corporation
- 7.4.4. Medline Inc.
- 7.4.5. Baxter International Inc.
- 7.4.6. CGE HealthCare Technologies, Inc.ompany 6
- 7.4.7. ResMed Inc.
- 7.4.8. Dragerwerk AG & Co. KGaA
- 7.4.9. Nidek Medical India
- 7.4.10. Fisher & Paykel Healthcare Corporation Limited
- 7.4.11. Nihon Kohden Corporation
- 7.4.12. Trudell Medical International
- 8. Strategic Recommendations
- 9. Annexure
- 9.1. FAQ`s
- 9.2. Notes
- 9.3. Related Reports
- 10. Disclaimer
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: North America Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 6: North America Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
Table 7: North America Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 8: United States Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 9: United States Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 10: Canada Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 11: Canada Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 12: Mexico Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 13: Mexico Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 14: Competitive Dashboard of top 5 players, 2025
Figure 2: North America Respiratory Devices Market Share By Country (2025)
Figure 3: US Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 4: Canada Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Mexico Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 6: Porter's Five Forces of Global Respiratory Devices Market
Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Our Clients
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 August, 2026)
- Notify To Team (09 August, 2026)
- Report updation (10 August, 2026)
- Report Quality Check (10 August, 2026)
- Report Dispatch (11 August, 2026)
- Hard Copy
Recently Viewed Products
North America Respiratory Care Devices Market Outlook, 2031
We are friendly and approachable, give us a call.